Can transient elastography be used for the management of chronic hepatitis B patients?

Liver International

Volumn 32, Issue 4, 2012, Pages 528-530

  Leroy, Vincent ^a,b   Kim, Seung Up ^c,d  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT ALBERT BONNIOT   (France)

^c Yonsei University College of Medicine   (South Korea)

^d Liver Cirrhosis Clinical Research Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; CANCER RISK; CHRONIC HEPATITIS; CHRONIC PATIENT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; EDITORIAL; ELASTOGRAPHY; FALSE POSITIVE RESULT; HEPATITIS; HEPATITIS B; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; VIRUS REACTIVATION;

ELASTICITY IMAGING TECHNIQUES; HEPATITIS B, CHRONIC; HUMANS;

EID: 84863253929     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2012.02768.x     Document Type: Editorial

References (16)

1. Marcellin P, Ziol M, Bedossa P, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009; 29: 242-7.
2. Tsochatzis EA, Gurusamy KS, Ntaoula S, et al. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 2011; 54: 650-9.
3. Verveer C, Zondervan PE, Ten Kate FJ, et al. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C. Liver Int 2012; 32: 622-8.
4. Cardoso AC, Carvalho-Filho RJ, Stern C, et al. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int 2012; 32: 612-21.
5. Sturm N, Cheveau A, Arvers P, et al. Comparative morphometric assessment of fibrosis in chronic hepatitis B versus chronic hepatitis C liver biopsies: implication for fibrosis assessement by non invasive methods. J Hepatol 2009; 50: S144.
6. Gaia S, Carenzi S, Barilli AL, et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011; 54: 64-71.
7. Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51: 454-62.
8. Roulot D, Czernichow S, Le Clesiau H, et al. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008; 48: 606-13.
9. Fraquelli M, Rigamonti C, Casazza G, et al. Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. J Hepatol 2011; 54: 621-8.
10. Liang XE, Chen YP, Zhang Q, et al. Dynamic evaluation of liver stiffness measurement to improve diagnostic accuracy of liver cirrhosis in patients with chronic hepatitis B acute exacerbation. J Viral Hepat 2011; 18: 884-91.
11. Fung J, Lai CL, Cheng C, et al. Mild-to-moderate elevation of alanine aminotransferase increases liver stiffness measurement by transient elastography in patients with chronic hepatitis B. Am J Gastroenterol 2011; 106: 492-6.
12. Kim SU, Kim do Y, Ahn SH, et al. The impact of steatosis on liver stiffness measurement in patients with chronic hepatitis B. Hepatogastroenterology 2010; 57: 832-8.
13. Myers RP, Pomier-Layrargues G, Kirsch R, et al. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. J Hepatol 2012; 56: 564-70.
14. Chan HL, Wong GL, Choi PC, et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 2009; 16: 36-44.
15. Kim SU, Seo YS, Cheong JY, et al. Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B. Aliment Pharmacol Ther 2010; 32: 498-505.
16. Jung KS, Kim SU, Ahn SH, et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 2011; 53: 885-94.